Patients often second-guess
their heart attack symptoms

Unfortunately, there is no way for patients to tell if the symptoms they are experiencing are due to an MI. As a result, patients often ignore symptoms and delay seeking care, which leads to worse outcomes and increased mortality.

Denial

Procrastination

Embarrassment

Crowded ER

Self-Diagnosis

Copayment

40% increased mortality rate2

for an average wait of 3-4 hours after symptoms begin

Yet the only other option is to go to the ER

Chest pain is the #2 most common reason for an ER visit

Chest pain is the second most common reason for an ER visit, yet fewer than 20% of chest pain ER visits result in a diagnosis of a life-threatening condition.3,4 These unnecessary ER visits lead to over $10B in unnecessary healthcare expenditures.5,6

82%

of chest pain ER visits
are unnecessary

$10 billion in cost to the US healthcare system.

Cost to the healthcare
system annually

Current telemedicine is fundamentally limited in its ability to detect heart attacks without a physician and medical quality ECG system in the patient's hands

HeartBeam provides a
personal, portable, and easy-to-use
heart attack detection solution*

HeartBeam provides a
personal, portable, and easy-to-use heart attack detection solution*

Always with the patient

Designed for heart attack detection

Full cardiovascular disease diagnostic
(12 lead capable)

With patient at time of event

Powerful diagnostic suggestion

Uses patient’s own baseline

HeartBeam has developed a system that can be used by patients at home to help their physicians assess whether chest pain is the result of an MI.

For the first time outside of a medical setting, physicians can determine with a patient-friendly device if chest pains are due to a heart attack.

HeartBeam AIMIGo™ Technology

HeartBeam AIMI™ and HeartBeam AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies.

HeartBeam offers a complete
solution for cardiovascular
‍patients and their physicians*

Learn more

Smartphone Application

Simple and intuitive patient and user interface

3D Vector Collection Device

Patient places credit card size device on chest for 30 sec signal recording

Heartbeam Cloud

Diagnostic suggestion & synthesized 12-lead ECG overlaid with baseline

Physician Portal

Physician views 12-lead ECG & diagnostic suggestion. Directs patient

HeartBeam is designed to deliver enhanced MI detection for millions of patients*

High risk patients with previous MI

8 million
patients in the US

Frequent
"false alarm"
ER visitors

+1 million
frequent low-risk ER visits

discharge patients after CV interventions

Patients after cardiovascular interventions

1 million
heart attack interventions

HeartBeam is designed to deliver enhanced MI detection for
‍millions of patients*

Tap each card to learn how HeartBeam helps

High CAD Risk / Patients with previous MI

8 million
patients in the US

Frequent "false alarm" ED visitors

+1 million
frequent low-risk ER visits

Patients after cardiovascular interventions

1 million
heart attack interventions

*CAUTION: Product not cleared by the FDA. Limited by United States law to investigational use.

World-class team leading HeartBeam with a
powerful mix of expertise and experience

Learn more about our history

Branislav Vajdic, PhD

CEO & Founder

Rich Ferrari

Executive Chairman

Rob Eno

President

Jon Hunt, PhD

Chief Business Officer

Rick Brounstein

Chief Financial Officer

Peter Fitzgerald, MD, PhD

Chief Medical Officer

Ken Persen

Chief Technology Officer

Marga Ortigas - Wedekind

Board Member

Wim Elfrink

Board Member

George de Urioste

Board Member

Strong studies demonstrate excellent performance

Harvard Cardiology Research Team conducted 4 studies // 1,210 HeartBeam 3D ECG files collected

HeartBeam 3D ECG has greater accuracy than cardiologists in detecting MI’s

Hides Study
N=186 recordings

HeartBeam 3D ECG has greater accuracy than cardiologists in detecting MI’s

Hides Study
N=186 recordings

HeartBeam 3D ECG has greater accuracy than cardiologists in detecting MI’s

Hides Study
N=186 recordings

HeartBeam 3D ECG has greater accuracy than cardiologists in detecting MI’s

Hides Study
N=186 recordings

*CAUTION: Product not cleared by the FDA. Not available for sale in the United States.

References:
1. https://www.cdc.gov/heartdisease/facts.htm
2. Saczynski JS, et al. (2008). Am Jrl. Cardiol;102(12): 1589-94
3. Agency for Healthcare Research and Quality, Statistical Brief #174, June 2014
4. Gibson CM et al. J Am Coll Cardiol. 2019 Apr, 73(15) 1919-1927
5. https://www.cdc.gov/nchs/data/nhamcs/web_tables/2020-nhamcs-ed-web-tables-508.pdf
6. https://www.talktomira.com/post/how-much-does-an-er-visit-cost
‍

HeartBeam provides a medical grade 12 Lead ECG that can be carried in a wallet

Massive and underserved market for remote heart attack detection

High CAD risk/patients with a previous MI

8 million
Patients in the US

Novel proprietary technology with strong IP protection

Four validation studies led by Harvard Medical School Faculty

FDA 510(k) regulatory path identified

Subscription telehealth business model using existing reimbursement codes

Medical grade heart attack detection

Patients often second-guess
their heart attack symptoms

HeartBeam provides a
personal, portable, and easy-to-use
heart attack detection solution*

HeartBeam provides a
personal, portable, and easy-to-use heart attack detection solution*

HeartBeam AIMIGo™ Technology